Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease.
Kiyohiko IzumiKozo MorimotoKazuhiro UchimuraManabu AtoNaoki HasegawaSatoshi MitaraiPublished in: ERJ open research (2020)
This report shows poor adherence to the recommended treatment regimen for NTM-PD patients, which may pose a potential risk for the development of macrolide resistance. The risk was highest among elderly patients, and those with rheumatoid arthritis and COPD. http://bit.ly/3aBoUzE.
Keyphrases
- rheumatoid arthritis
- end stage renal disease
- mycobacterium tuberculosis
- newly diagnosed
- ejection fraction
- chronic obstructive pulmonary disease
- chronic kidney disease
- pulmonary hypertension
- peritoneal dialysis
- lung function
- emergency department
- cross sectional
- pulmonary tuberculosis
- disease activity
- interstitial lung disease
- skeletal muscle
- risk assessment
- systemic sclerosis
- human immunodeficiency virus
- patient reported
- adverse drug
- breast cancer risk